MediFind, a data-powered online provider directory offered by Phreesia, is announcing the launch of Chloe, its new "Find the Right Provider" chatbot. Chloe is designed to guide patients step by step through the process of finding a provider who fits their needs. It removes challenges around finding care that so often lead to incorrect bookings, scheduling setbacks or abandoning the search for care altogether.

Finding the right doctor—whether for a chronic condition, a specialist referral or a rare disease—can feel overwhelming. Patients may know the type of care they need, but navigating insurance coverage, provider availability and new patient requirements can quickly become a barrier. Chloe addresses this directly by capturing relevant patient information upfront and surfacing tailored provider matches drawn from MediFind’s database of more than 2 million clinicians.

When patients open Chloe on MediFind.com, they are guided through a short conversational intake, including questions about the type of care they are looking for, their location, insurance and any personal preferences. The chatbot then presents provider matches tailored to their answers. Patients can review profiles, compare options and, when a provider feels right, move forward with requesting an appointment directly through the platform. By guiding patients through the process and capturing the right details up front with AI-powered features, the tool makes it easier to find a provider who fits and book with more confidence.

"We built Chloe because we know that finding the right provider is about more than search results, it’s about guidance," said David Linetsky, President of Phreesia Network Solutions. "By asking the right questions up front, we make it easier for patients to find a provider who actually fits their care needs."

Access to the right specialist remains one of the most persistent challenges in healthcare. MediFind uses advanced analytics to help consumers navigate the provider search process with data-driven, evidence-based information, making it more efficient and impactful. Chloe deepens that capability by bringing a more personalized, guided experience to patients managing complex, chronic and rare conditions, where finding the right expert can directly affect treatment outcomes.

Phreesia acquired MediFind in July 2023. To learn more about MediFind, visit MediFind.com.

About Phreesia

Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 180 million patient visits in 2025—1 in 6 visits across the U.S. This scale allows Phreesia to make meaningful impact across the healthcare ecosystem. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives operational efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

About MediFind

MediFind is a data science and consumer-centric health technology company, focusing on connecting patients with leading experts, clinical trials, health systems, and healthcare technologies through advanced analytics. The company employs machine learning techniques and artificial intelligence technologies to synthesize the latest information from around the globe on a range of chronic and rare conditions with the goal of helping patients make more informed health decisions faster. Learn more about MediFind at www.medifind.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260721246106/en/

media@phreesia.com